Therapy for ADHD: Natural Treatment Option https://www.additudemag.com ADHD symptom tests, ADD medication & treatment, behavior & discipline, school & learning essentials, organization and more information for families and individuals living with attention deficit and comorbid conditions Tue, 14 Jan 2025 22:18:21 +0000 en-US hourly 1 https://wordpress.org/?v=6.6.2 https://i0.wp.com/www.additudemag.com/wp-content/uploads/2020/02/cropped-additude-favicon-512x512-1.png?w=32&crop=0%2C0px%2C100%2C32px&ssl=1 Therapy for ADHD: Natural Treatment Option https://www.additudemag.com 32 32 216910310 33 Ways to Prioritize Your Mental Health in the New Year https://www.additudemag.com/how-to-improve-mental-health-adhd-apps-tips/ https://www.additudemag.com/how-to-improve-mental-health-adhd-apps-tips/?noamp=mobile#respond Mon, 16 Dec 2024 10:22:03 +0000 https://www.additudemag.com/?p=368125

We make time for everything and everyone but ourselves. We consistently prioritize the needs of others. We feel guilty erecting boundaries. And this struggle to carve out space for our own wellbeing is the biggest barrier to mental and emotional health for more than half of adults with ADHD, according to a new survey of 1,898 ADDitude readers.

“I have a hard time putting myself first. I worry about others to my own detriment.”

“I really want to journal but, when I remember to, I spend an hour writing and then find myself thinking, ‘I don’t have time for this!’”

On a 10-point scale, where 10 is extremely satisfied, ADDitude readers rated their mental and emotional health a 5.2. Additional barriers to mental health care cited by readers include the following:

  • Defining effective self-care strategies: 45%
  • Sticking with a routine: 45%
  • Practicing mindful meditation and/or gratitude: 38%
  • Affording a mental-health practitioner: 23%

“Insurance makes things impossible sometimes. Also, I’ve had to switch mental healthcare doctors many times due to clashes of ideals and personality. One actually said ADHD wasn’t real and that I just needed discipline to work through my ‘laziness’.”

“I have not found a single counselor who is highly familiar with adult ADHD and its nasty companions.”

[Get This Free Download: Make Mindfulness Work for You]

Top Mental Health Apps and Tools

Following are the top apps, websites, podcasts, books, and other resources recommended by ADDitude readers for improving mental and emotional health.

Self-Care Apps

  • Insight Timer: Guided meditation sessions, music, and courses for mindfulness and relaxation
  • Balance: Personalized meditation that adapts sessions to your goals and progress
  • Gratitude: Foster daily gratitude and positivity via journaling
  • Happify: Activities and games to boost happiness and reduce stress
  • Headspace: Mindfulness and meditation tools, sleep sounds, mindful movement, and exercise.
  • Calm: Sleep stories and music, meditation and inspirational stories, mood tracking, and relaxation tools
  • Healthy Minds: Unlock wellbeing my practicing four skills — awareness, connection, insight, and purpose
  • Finch: Nurture a virtual pet by completing daily wellness and self-care tasks

Self-Care YouTube Channels, Podcasts, and Websites

  • How to ADHD: A YouTube channel created by Jessica McCabe that offers practical tools and insights for living with ADHD.
  • The Happiness Lab: A podcast by Laurie Santos, Ph.D., that explores science-backed strategies for a happier life.
  • The Teen Anxiety Maze : A podcast by Cynthia Coufal, a teen anxiety coach.
  • Therapy in a Nutshell : A mental health and strategies podcast, YouTube channel, and website by Emma McAdam, LMFT.
  • Something Shiny: A podcast by therapists David Kessler and Isabelle Richards that tackles ADHD and relationships with humor and authenticity.
  • ADDitude ADHD Experts: Leading experts in ADHD and mental health share the latest research and proven strategies.

Self-Care Books

Daily Self-Care Approaches

To prioritize self-care, many ADDitude readers incorporate small practices and routines into daily life. Here is their advice.

Take three deep breaths a few times a day. Connect it to something you are doing anyway; do it after going to the bathroom first thing in the morning or when you get into your car.”

“I have a ‘blow off steam’ playlist that I listen to when I feel wired or hostile. (I also have calming playlists!)”

“As weird as it sounds, I find ChatGPT great for journaling. It asks me questions about what I’ve written and helps me develop a deeper understanding of my thoughts.”

Exercise is the magic medicine for my mental health. I notice a difference in my energy, focus, attitude, and motivation to get things done when I exercise. I try to walk three days a week and attend a class at my local YMCA three days a week.”

I write about three good things every morning. It gives me a sense of achievement and agency and calms my anxiety.”

“I have set aside Fridays after work as ‘nothing needs to get done’ time.”

“I try to have 30 minutes of ‘me’ time every day. I take a bath, listen to an audiobook, or watch a show.”

[Read: 31 Ways to Work Out the Kinks in Your Workout Plan]

The Power of Therapy and Medication for Mental Health

Readers report that taking prescribed medications and working with mental health professionals do wonders for their health, and assigned the following “helpfulness” ratings to each tool (on a 5-point scale where 5 is extremely helpful):

  • Therapist (in-person or online): 4.11
  • Medication for ADHD: 3.91
  • Medication for another condition: 3.88
  • Psychiatrist: 3.67

“ADHD meds have helped so much with emotional regulation that I’m quite upset I didn’t have access to them earlier!”

“Medication for anxiety has largely cleared up my ADHD mess, so much that I’m able to handle other sides that come up (time blindness, forgetfulness, etc.)”

“Accessing a therapist is paramount to understanding your emotions, triggers, and boundaries.”

“Medication can be so helpful, but it can take a while to figure out what works for you. Try some stuff and don’t be afraid to try something else if it is not working or if side effects make life unfun. Also, know that medication is a helpful tool, but it doesn’t do the work for you. It helps you do the work of setting up systems, finding coping skills and accommodations, and looking honestly at how your current patterns are helping or hurting you as you seek to be the best you.”

More Recommended Mental Health Supports

What other supports are helpful for improving mental and emotional health? ADDitude readers contributed the following “helpfulness” ratings:

  • ADHD coach: 3.67
  • Yoga or meditation class: 3.50
  • Spouse, family member, friend: 3.38
  • Anger-management training: 2.75
  • Journaling: 3.08

“Get a good yoga teacher who focuses on the emotional benefits of yoga as well as the physical benefits. It is so much more than exercise and is really beneficial for all sorts of ADHD symptoms, too.”

“Find safe spaces to talk about your feelings, even if it is just an online community of strangers. Communities of people with ADHD are great to engage with because they have empathy for what you are experiencing and often really great advice for ways to better your daily life.”

There is something therapeutic about writing on paper while curled up in a chair. It clears my mind and gets the chaos out of my head.”

“My most helpful experiences come from seeing others with similar struggles and finding that I am normal.”

How to Improve Mental Health: Next Steps


SUPPORT ADDITUDE
Thank you for reading ADDitude. To support our mission of providing ADHD education and support, please consider subscribing. Your readership and support help make our content and outreach possible. Thank you.

#CommissionsEarned As an Amazon Associate, ADDitude earns a commission from qualifying purchases made by ADDitude readers on the affiliate links we share. However, all products linked in the ADDitude Store have been independently selected by our editors and/or recommended by our readers. Prices are accurate and items in stock as of time of publication.

]]>
https://www.additudemag.com/how-to-improve-mental-health-adhd-apps-tips/feed/ 0 368125
The Future of ADHD Research: Promising Frontiers https://www.additudemag.com/adhd-research-predictions-gut-brain-epigenetics-medication/ https://www.additudemag.com/adhd-research-predictions-gut-brain-epigenetics-medication/?noamp=mobile#respond Tue, 05 Nov 2024 10:53:57 +0000 https://www.additudemag.com/?p=366722 As we explore groundbreaking advances in ADHD care and treatment over the coming years, three areas of research are particularly exciting to me. They involve new pharmacologic interventions; studies of the gut-brain link and the impact of the gut microbiome on brain functioning; and an increased understanding of specific variants of ADHD arising from different combinations of gene-environment influences. All of these could unlock personalized interventions.

In this final installment of ADDitude magazine’s two-part series, “The Future of ADHD” (the first part appeared in the Winter 2023 issue), I’ll explain each of the developments poised to revolutionize ADHD understanding and treatment.

New Pharmacologic Interventions for ADHD

Development of pharmacologic interventions for ADHD has mushroomed over the last two decades. Though researchers have made progress in developing non-stimulant treatment options (i.e., long-acting forms of clonidine and guanfacine, as well as atomoxetine and viloxazine), most of the FDA-approved agents are simply tweaks of methylphenidate and amphetamine compounds.

There are now more choices available to prescribers and patients, offering stimulant preparations of varying durations, delivery formats (patch, liquid, tablet, capsule), and pharmacokinetic profiles. It should be noted that both older and newer preparations are exceptionally effective for most patients and, when comparing them to non-stimulants in head-to-head trials and in clinical practice, the psychostimulants generally win hands-down. However, the various forms of psychostimulants differ in their rate of onset, duration of coverage, convenience (once daily vs. multiple doses daily), and cost.

Psychostimulants, however, are not effective for everyone; about 30% of patients may not have a satisfactory response.1 As a result, researchers are increasingly exploring the benefits of combining psychostimulant treatment with other compounds (e.g., methylphenidate paired with atomoxetine, or a dextroamphetamine compound plus guanfacine).

[Get This Free Download: 2024 Scorecard of ADHD Treatments]

The robust effectiveness of psychostimulants in treating ADHD has somewhat slowed the development of alternatives. However, researchers are exploring newer agents that target different neurotransmitter systems, including:

  • Solriamfetol (used to treat excessive daytime drowsiness)
  • Tipepidine (used as a cough suppressant)
  • Amantadine (used to treat Parkinson’s disease)
  • Dasotraline (used to treat depression and other disorders)

Not yet FDA-approved for ADHD, these compounds face two main challenges: matching the effectiveness of psychostimulants and effectively targeting symptoms not currently treated by psychostimulants.

ADHD and the Gut-Brain Axis

Emerging research suggests a significant, but underappreciated, relationship between the gut biome — a diverse community of microorganisms living in the digestive tract — and behavior and emotions. The gut and the brain communicate through the gut-brain axis, allowing gut microbiota to influence brain function and vice versa.

Multiple studies have now shown that abnormalities in the gut microbiome can affect mood, anxiety, and stress levels.2 Certain gut bacteria can even produce neurotransmitters like serotonin and gamma-aminobutyric acid (GABA), which play a crucial role in regulating emotions.3 Other gut bacteria can produce toxins, inflammatory molecules, and other metabolites that can cross the blood-brain barrier to adversely impact brain health and cognitive function.4

[Get This Free Download: Lifestyle Changes for Adults with ADHD]

Imbalances in the gut microbiome can be caused by diet, stress, and even antibiotic use during the prenatal period or during infancy.5 6 Longitudinal studies have shown that these gut factors can be linked to mental health disorders, including ADHD, in later childhood.7 Multiple studies also suggest that restoring a healthy gut balance through probiotics, prebiotics, or dietary changes might improve emotional wellbeing.8 Research involving the microbiome’s impact on human behavior and emotions is still emerging.

ADHD and Gene-Environment Interactions

ADHD is highly heritable; however, environmental influences are exceptionally important in determining whether, when, and how a set of genes will manifest in ADHD symptoms. Environments determine whether a particular illness or disease manifests. This area of research — how certain genes are differentially expressed due to differences in environments — is in its infancy.

A major challenge: Because there are so many genes and possible environmental factors unfolding over time, there are literally trillions of possible gene-environment interactions that could affect the timing, severity, and persistence of ADHD. Due to the likely number and complexity of these interactions, multiple replications across independent studies will be essential.

Several studies have already shown that the severity and persistence of ADHD can be a function of parent-child interactions and supervision across different settings.9 This is not a “blame the parents” finding, but, instead, suggests that certain interventions from caregivers (and possibly teachers, coaches, and other adults) may mitigate a child’s symptom severity and persistence. For example, teaching parents how to remain neutral, or even express warmth in the face of difficult behaviors, is likely an important area of intervention. Related findings indicate that parental rejection10 can affect a child’s outcomes, as can the level of household disorganization11, overall life stress12, and other factors. Attention to such challenges offers an opportunity for targeted interventions.

Many different factors contribute to ADHD’s etiology, timing of onset, and severity, as well as possibilities for prevention and person-specific treatment. Our research to date, and our research programs unfolding over the next decades, will continue to lead to advances in the way we diagnose and treat ADHD in childhood and in adults.

ADHD Research: Next Steps

Peter S. Jensen, M.D., is the founder of The REACH Institute, which trains providers in interventions for children’s mental health care.


SUPPORT ADDITUDE
Thank you for reading ADDitude. To support our mission of providing ADHD education and support, please consider subscribing. Your readership and support help make our content and outreach possible. Thank you.

Sources

1 Spencer, T., Biederman, J., & Wilens, T. (2004). Nonstimulant treatment of adult attention-deficit/hyperactivity disorder. The Psychiatric clinics of North America, 27(2), 373–383. https://doi.org/10.1016/j.psc.2003.12.001

2 Xiong, R. G., Li, J., Cheng, J., Zhou, D. D., Wu, S. X., Huang, S. Y., Saimaiti, A., Yang, Z. J., Gan, R. Y., & Li, H. B. (2023). The Role of Gut Microbiota in Anxiety, Depression, and Other Mental Disorders as Well as the Protective Effects of Dietary Components. Nutrients, 15(14), 3258. https://doi.org/10.3390/nu15143258

3 Chen, Y., Xu, J., & Chen, Y. (2021). Regulation of Neurotransmitters by the Gut Microbiota and Effects on Cognition in Neurological Disorders. Nutrients, 13(6), 2099. https://doi.org/10.3390/nu13062099

4 Parker, A., Fonseca, S., & Carding, S. R. (2020). Gut microbes and metabolites as modulators of blood-brain barrier integrity and brain health. Gut microbes, 11(2), 135–157. https://doi.org/10.1080/19490976.2019.1638722

5 Madison, A., & Kiecolt-Glaser, J. K. (2019). Stress, depression, diet, and the gut microbiota: human-bacteria interactions at the core of psychoneuroimmunology and nutrition. Current opinion in behavioral sciences, 28, 105–110. https://doi.org/10.1016/j.cobeha.2019.01.011

6 Fish-Williamson, A., Hahn-Holbrook, J., Hobbs, M., Wallander, J., & Morton, S. M. B. (2022). Prenatal antibiotic exposure in pregnancy and early childhood socioemotional development. JCPP advances, 2(2), e12066. https://doi.org/10.1002/jcv2.12066

7 Cassidy-Bushrow, A. E., Sitarik, A. R., Johnson, C. C., Johnson-Hooper, T. M., Kassem, Z., Levin, A. M., Lynch, S. V., Ownby, D. R., Phillips, J. M., Yong, G. J. M., Wegienka, G., & Straughen, J. K. (2023). Early-life gut microbiota and attention deficit hyperactivity disorder in preadolescents. Pediatric research, 93(7), 2051–2060. https://doi.org/10.1038/s41390-022-02051-6

8 Bistas, K. G., & Tabet, J. P. (2023). The Benefits of Prebiotics and Probiotics on Mental Health. Cureus, 15(8), e43217. https://doi.org/10.7759/cureus.43217

9Haack, L. M., Villodas, M. T., McBurnett, K., Hinshaw, S., & Pfiffner, L. J. (2016). Parenting Mediates Symptoms and Impairment in Children With ADHD-Inattentive Type. Journal of clinical child and adolescent psychology : the official journal for the Society of Clinical Child and Adolescent Psychology, American Psychological Association, Division 53, 45(2), 155–166. https://doi.org/10.1080/15374416.2014.958840

10 Brinksma, D. M., Hoekstra, P. J., de Bildt, A., Buitelaar, J. K., van den Hoofdakker, B. J., Hartman, C. A., & Dietrich, A. (2023). Parental rejection in early adolescence predicts a persistent ADHD symptom trajectory across adolescence. European child & adolescent psychiatry, 32(1), 139–153. https://doi.org/10.1007/s00787-021-01844-0

11 Agnew-Blais, J. C., Wertz, J., Arseneault, L., Belsky, D. W., Danese, A., Pingault, J. B., Polanczyk, G. V., Sugden, K., Williams, B., & Moffitt, T. E. (2022). Mother’s and children’s ADHD genetic risk, household chaos and children’s ADHD symptoms: A gene-environment correlation study. Journal of child psychology and psychiatry, and allied disciplines, 63(10), 1153–1163. https://doi.org/10.1111/jcpp.13659

12 Hartman, C. A., Rommelse, N., van der Klugt, C. L., Wanders, R. B. K., & Timmerman, M. E. (2019). Stress Exposure and the Course of ADHD from Childhood to Young Adulthood: Comorbid Severe Emotion Dysregulation or Mood and Anxiety Problems. Journal of clinical medicine, 8(11), 1824. https://doi.org/10.3390/jcm8111824

]]>
https://www.additudemag.com/adhd-research-predictions-gut-brain-epigenetics-medication/feed/ 0 366722
Free Download: What Is Dialectical Behavior Therapy (DBT)? https://www.additudemag.com/download/dialectical-behavior-therapy-dbt-adhd/ https://www.additudemag.com/download/dialectical-behavior-therapy-dbt-adhd/?noamp=mobile#respond Wed, 02 Oct 2024 15:43:51 +0000 https://www.additudemag.com/?post_type=download&p=364086

Dialectical behavior therapy (DBT) combines elements of mindfulness and cognitive behavioral therapy (CBT) to treat conditions marked by emotional dysregulation, including ADHD, mood disorders, and anxiety disorders.

Initially developed by Marsha Linehan, Ph.D., in the 1980s to treat borderline personality disorder (BPD), DBT helps people learn to tolerate internal experiences (i.e., emotions), physical sensations (i.e., agitation and restlessness), and the urge to fidget or interrupt. It has become a go-to treatment for ADHD.

A central tenet of DBT is validation — accepting uncomfortable emotions and situations before trying to change them. By coming to terms with troubling thoughts and emotions, change appears possible, and patients can work with their therapists to create a recovery plan.

In this download, you will learn:

 

]]>
https://www.additudemag.com/download/dialectical-behavior-therapy-dbt-adhd/feed/ 0 364086
“How DBT Promotes Emotional Regulation, Distress Tolerance, and Mindfulness” [Video Replay & Podcast #527] https://www.additudemag.com/webinar/dbt-adhd-adult-treatment-guide/ https://www.additudemag.com/webinar/dbt-adhd-adult-treatment-guide/?noamp=mobile#respond Thu, 19 Sep 2024 16:06:09 +0000 https://www.additudemag.com/?post_type=webinar&p=363476 Episode Description

Dialectical Behavior Therapy (DBT) is an effective treatment for improving emotional regulation in adults with ADHD. DBT is a lesser known but important intervention under the Cognitive Behavioral Therapy (CBT) umbrella of treatments for ADHD.

DBT aims to improve emotional dysregulation through four basic skills modules: core mindfulness, distress tolerance, emotion regulation, and interpersonal effectiveness. DBT modified for adult ADHD also integrates skills that improve executive function.

In this webinar, you will learn:

  • About basic DBT skills modules and how they are modified to treat adult ADHD symptoms and traits
  • How DBT teaches skills to improve management of intense emotions, impulsivity, mood swings, stress intolerance, and related behaviors
  • How DBT teaches skills to improve executive functioning
  • How DBT teaches approaches to activate the emotions needed for task initiation and persistence
  • About the actionable strategies that DBT provides to bring about lasting changes in behavior and motivation

Watch the Video Replay

Enter your email address in the box above labeled “Video Replay + Slide Access” to watch the video replay (closed captions available) and download the slide presentation.

Download or Stream the Podcast Audio

Click the play button below to listen to this episode directly in your browser, click the symbol to download to listen later, or open in your podcasts app: Apple Podcasts; Audacy; Spotify; Amazon Music; iHeartRADIO

DBT Skills for ADHD Symptoms: More Resources

Obtain a Certificate of Attendance

If you attended the live webinar on October 31, 2024, watched the video replay, or listened to the podcast, you may purchase a certificate of attendance option (cost: $10). Note: ADDitude does not offer CEU credits. Click here to purchase the certificate of attendance option »


Meet the Expert Speaker

Scott Spradlin, a licensed professional counselor and licensed master’s addiction counselor, is the co-director of Wichita DBT at NorthStar Therapy, along with his wife, Mariah Spradlin, a licensed clinical social worker and licenses clinical addiction counselor. They provide adherent comprehensive DBT and Wise Mind for the Distracted Mind: DBT for Adult ADHD, a modified DBT for adult ADHD.

Scott completed DBT intensive training with DBT founder Marsha Linehan, Ph.D., and Linda Dimeff, Ph.D., in 2000 in Seattle, Washington. He served as an adjunct professor for the College of Education and School Psychology at Wichita State University, where he taught courses on DBT and related topics, the assessment and treatment of suicidality and self-harm, and the ethical integration of religion and spirituality in psychotherapy for undergraduate and graduate students. Scott authored Don’t Let Your Emotions Run Your Life: How Dialectical Behavior Therapy Can Put You in Control (New Harbinger, 2003).

He and his wife are co-authoring a new workbook on DBT for adult ADHD scheduled for release in 2026.


Listener Testimonials

“I found today’s webinar to provide a great overview of how DBT principles can be applied to ADHD treatment.”

“I’m a psychologist with ADHD specializing in ADHD and I loved this! I’ve done some generic DBT training but there was so much in this and so much that’s relevant to my clients and I.”

“Absolutely brilliant speaker. That was excellent; so gentle and kind for us ADHD adults and yet loads of really good theory and simple steps that could really help.”


Webinar Sponsor

The sponsor of this ADDitude webinar is….

 

 

Are your emotions taking you on a rollercoaster you can’t control? You’re not alone. For adults with ADHD, managing feelings can be tough. That’s where Inflow steps in. Our expert-designed app-based program offers practical techniques to help you identify thought patterns, regulate emotions, and boost your overall well-being. With Inflow, you’re not just surviving – you’re thriving. Ready to take charge of your emotional world for good? Take the free ADHD quiz today to kick off your self-care journey.

ADDitude thanks our sponsors for supporting our webinars. Sponsorship has no influence on speaker selection or webinar content.


Follow ADDitude’s full ADHD Experts Podcast in your podcasts app:
Apple Podcasts | Spotify | Google Play | Amazon Music | RadioPublic | Pocket Casts | iHeartRADIO | Audacy

]]>
https://www.additudemag.com/webinar/dbt-adhd-adult-treatment-guide/feed/ 0 363476
EndeavorOTC https://www.additudemag.com/treatment/endeavorotc/ https://www.additudemag.com/treatment/endeavorotc/?noamp=mobile#respond Mon, 24 Jun 2024 17:09:18 +0000 https://www.additudemag.com/?post_type=treatment&p=358028 What is EndeavorOTC?

EndeavorOTC is an over-the-counter digital therapeutic authorized by the Food and Drug Administration (FDA) for the treatment of adults 18 and older with primarily inattentive or combined-type ADHD. In the U.S., it is indicated to improve attention and functioning as measured by computer-based testing. It is available without a prescription.

EndeavorOTC is not intended to be used as a stand-alone therapeutic and is not a substitution for ADHD medication.

Developed by Akili Interactive, EndeavorOTC is the first FDA-authorized over-the-counter digital therapeutic treatment for adult ADHD. It uses the same proprietary technology as EndeavorRx, an FDA-approved digital therapeutic for the treatment of children ages 8 to 12 with primarily inattentive or combined-type ADHD.

EndeavorOTC is available in the U.S. in the Apple App Store for iOS and the Google Play Store for Android mobile devices.

How Does EndeavorOTC Work?

Through its immersive video game experience, EndeavorOTC presents specific sensory stimuli and simultaneous motor challenges designed to alter pathways in the brain related to focus.

Adults typically interact with EndeavorOTC on mobile devices for 25 minutes daily, five days a week.

The EndeavorOTC games, which challenge players to simultaneously target and navigate through a series of obstacles, are designed to boost cognitive functions related to attention, focus, multitasking, and prioritization.

How Long Does EndeavorOTC Take to Work?

The clinical study supporting EndeavorOTC’s FDA clearance found that, after six weeks of EndeavorOTC use, 83% of participants saw clinical improvements in their ability to focus as measured by the TOVA attentional control score. Nearly three-quarters (72.5%) of participants reported some quality-of-life improvements as measured by the Adult ADHD Quality of Life Scale (AAQoL), and roughly half (45.8%) of adults met a prespecified threshold for clinically meaningful improvement.1

What are the Side Effects of EndeavorOTC?

The clinical trial for EndeavorOTC reported no lasting or serious side effects. Of the 221 adults who received EndeavorOTC for six weeks in the trial, 11 (5%) reported a treatment-emergent adverse device event, most commonly nausea (1.8%) and headache (1.4%).1

What Precautions are Associated with EndeavorOTC?

EndeavorRx may not be appropriate for patients with photosensitive epilepsy, color blindness, or physical limitations that stop a patient from comfortably holding a device.

To learn more about EndeavorOTC, visit EndeavorOTC.com.

What is EndeavorRX?

EndeavorRx, a version of EndeavorOTC designed for children ages 8 to 12 with ADHD, was approved by the FDA in June 2020. Through its immersive video game experience, EndeavorRx presents specific sensory stimuli and simultaneous motor challenges designed to target neural systems in the brain related to attentional control. Children interact with EndeavorRx on mobile devices and typically play for 25 minutes per day, five days a week. It is available by prescription from a licensed healthcare provider.

Learn more about EndeavorRx at www.endeavorrx.com/

Source

1 Stamatis, C.A., Mercaldi, C., Kollins, S.H. (2023). A Single-Arm Pivotal Trial to Assess the Efficacy of Akl-T01, a Novel Digital Intervention for Attention, in Adults Diagnosed With ADHD. Journal of the American Academy of Child & Adolescent Psychiatry. https://doi.org/10.1016/j.jaac.2023.09.510

 

]]>
https://www.additudemag.com/treatment/endeavorotc/feed/ 0 358028
The Real-Deal Guide to Complementary Treatments for ADHD https://www.additudemag.com/slideshows/alternative-therapies-fish-oil-neurofeedback-workout-adhd/ https://www.additudemag.com/slideshows/alternative-therapies-fish-oil-neurofeedback-workout-adhd/?noamp=mobile#respond Fri, 15 Mar 2024 09:01:03 +0000 https://www.additudemag.com/?post_type=slideshow&p=350152 https://www.additudemag.com/slideshows/alternative-therapies-fish-oil-neurofeedback-workout-adhd/feed/ 0 350152 “Psychedelic Therapy for Mood Disorders: Research & Potential” [Video Replay & Podcast #502] https://www.additudemag.com/webinar/psychedelic-therapy-for-mood-disorders/ https://www.additudemag.com/webinar/psychedelic-therapy-for-mood-disorders/?noamp=mobile#respond Thu, 14 Mar 2024 20:27:57 +0000 https://www.additudemag.com/?post_type=webinar&p=351115 Episode Description

The therapeutic potential of psychedelic drugs for treatment-resistant conditions including mood disorders has sparked renewed interest among researchers, psychiatrists, and patients. New research and ongoing clinical trials are shedding light on the safety and efficacy of these substances, used in controlled therapeutic settings, for conditions that have been challenging to treat using conventional methods. A growing body of research indicates that several classical psychedelics and “psychedelic-like” compounds (e.g. psilocybin, ketamine, MDMA, and LSD) have shown promise for the treatment of substance use disorders, post-traumatic stress disorder (PTSD), anxiety disorders, and treatment-resistant depression (TRD). Some psychedelic treatments, such as MDMA-assisted psychotherapy for PTSD, are currently undergoing phase 3 clinical trials, indicating a significant level of scientific and medical interest in their potential therapeutic applications.

In this webinar, you will learn about:

  • The history of psychedelic therapy and its research
  • The science behind how psychedelic compounds may be targeting clinical conditions, like major depressive disorder
  • The possible benefits and side effects of using psychedelics to conditions after other conventional therapies have failed
  • What questions to ask when considering psychedelic usage in a clinical setting for yourself or loved ones

Watch the Video Replay

Enter your email address in the box above labeled “Video Replay + Slide Access” to watch the video replay (closed captions available) and download the slide presentation.

Download or Stream the Podcast Audio

Click the play button below to listen to this episode directly in your browser, click the  symbol to download to listen later, or open in your podcasts app: Apple Podcasts; AudacySpotifyAmazon MusiciHeartRADIO.

Treatment for Mood Disorders: More Resources

Obtain a Certificate of Attendance

If you attended the live webinar on April 23, 2024, watched the video replay, or listened to the podcast, you may purchase a certificate of attendance option (cost: $10). Note: ADDitude does not offer CEU credits. Click here to purchase the certificate of attendance option »


Meet the Expert Speaker

Adrian Jacques H. Ambrose, M.D., MPH, MBA, FAPA, is the Senior Medical Director at ColumbiaDoctors Psychiatry at Columbia University Irving Medical Center. For over a decade, Dr. Ambrose has also served as a senior consultant in designing national and global programming in strategy, management, and operations implementation for mid-to-large-sized entities, including Fortune 500 companies. In addition, he specializes in cultivating psychological safety, team building, and culture acceleration for senior managers and executives.

Clinically, Dr. Ambrose specializes in treatment-refractory mood disorders for both the adult, child, and adolescent populations in interventional and novel therapeutics, such as neuronavigated TMS, ketamine, and psychedelics.

Dr. Ambrose completed his medical training at Dartmouth and MGH/McLean Hospital, and value-based healthcare training at the Dartmouth Institute for Health Policy. He also completed the Minority Health Policy Fellowship at Harvard Medical School.


Listener Testimonials

“Excellent information and points about balancing the potential therapeutic uses with the clinical evidence at the moment.”

“Thank you for providing so much info for practitioners! It is very helpful.”

“Great speaker! I would definitely take another of his courses!”


Follow ADDitude’s full ADHD Experts Podcast in your podcasts app:
Apple Podcasts | Google Podcasts | Spotify | Google Play | Amazon Music | RadioPublic | Pocket Casts | iHeartRADIO | Audacy

]]>
https://www.additudemag.com/webinar/psychedelic-therapy-for-mood-disorders/feed/ 0 351115
“How a Psychedelic Trip Changed My Life” https://www.additudemag.com/psychedelic-assisted-therapy-shrooms-depression-adhd/ https://www.additudemag.com/psychedelic-assisted-therapy-shrooms-depression-adhd/?noamp=mobile#comments Tue, 20 Feb 2024 20:08:21 +0000 https://www.additudemag.com/?p=348099 Twelve years ago, I embarked on a transformative psychedelics journey that opened my eyes to my true self. I did not know then that this trip into my subconscious would completely change my perception of the world, make my then-undiagnosed ADHD more manageable, and lead me to help others experience similar life-changing revelations.

On that fateful day, my psychedelic guide gave me magic mushrooms and said, “Look at the forest one last time; you will never see it the same way again.”

To say he was right would be an understatement.

I arrived with a simple intention: to get to know myself better. What emerged were aspects of myself that I never knew existed. The psychedelic experience revealed the roots of my depression and provided insight about how to regulate my emotions — a godsend for me as I struggled with intense mood swings and disorders. Whereas therapy had failed, this journey transformed me entirely.

To be clear, it was not a magical solution that solved all my problems overnight. But my psychedelic journey gave me a vision of the destination to drive toward. It filled me with an intrinsic motivation to change the patterns that were keeping me stuck.

[Read: The Truth About Lion’s Mane, Psychedelics & Caffeine]

Fast-forward 12 years, following numerous psychedelic experiences combined with therapy: I have achieved a state of emotional stability. Severe mood swings and depression are a distant memory.

I was diagnosed with ADHD last year, and I consider this revelation the last missing piece of my puzzle. Today, I find it easy to love myself for who I am. I have developed new ways to live and embrace my ADHD brain without using medication.

Helping Others Follow the White Rabbit

In 2016, I decided that I wanted to help others by becoming a psychedelic-assisted therapy facilitator. At the time, psychedelic facilitator training programs didn’t exist, so I pursued extensive training in various modalities. I trained in inner child work and trauma integration therapy. I attended workshops and seminars conducted by experts in the field of psychedelic-assisted therapy.

Since then, I have co-founded a psychedelic-assisted therapy company and guided hundreds of people through psilocybin journeys in the Netherlands, where this work is legal. The changes I have witnessed in people, especially those with ADHD and neurodiversity, have been nothing short of astounding.

[From WebMD: A Long, Strange Trip — Psychedelics Meet Mainstream Medicine]

Most of the people undergoing this form of therapy experience significant changes in their lives, overcome addictions and depression, transform their self-doubt, and reduce their rejection sensitivity.

It is important to say that this therapy is not for everyone, nor is it a one-size-fits-all solution. Individuals who are prone to psychosis, diagnosed with schizophrenia or bipolar disorder, or who have a family history of these conditions should abstain from this therapy.

That said, it helped me to redefine my life, and I hope it can benefit others like me.

Psychedelic Assisted Therapy: Next Steps

Alice Smeets is a neurodivergent psilocybin-assisted therapy facilitator and co-founder of The Inner Shift Institute, which offers guided, private psilocybin therapy sessions and group retreats in the Netherlands.


SUPPORT ADDITUDE
Thank you for reading ADDitude. To support our mission of providing ADHD education and support, please consider subscribing. Your readership and support help make our content and outreach possible. Thank you.

]]>
https://www.additudemag.com/psychedelic-assisted-therapy-shrooms-depression-adhd/feed/ 1 348099
Special Report: ADHD Treatments Scorecard from ADDitude Readers https://www.additudemag.com/adhd-treatments-scorecard-medication-therapy-supplements-exercise/ https://www.additudemag.com/adhd-treatments-scorecard-medication-therapy-supplements-exercise/?noamp=mobile#comments Thu, 18 Jan 2024 04:21:27 +0000 https://www.additudemag.com/?p=347307 ADHD medication remains a magnet for debate, confusion, and promise.

Amphetamine and methylphenidate have been used to treat ADHD for at least 80 years, and their safety and efficacy have been studied relentlessly. But according to a recent ADDitude survey, less than half (42%) of parents opt to medicate their children in the months after a diagnosis, largely due to the fear of real or perceived side effects like appetite suppression or sleep disruption — both possible impediments to growth.

In the end, 85%  of all people with ADHD end up taking medication and they rate its efficacy higher than any other treatment approach included in the survey, ADDitude’s largest to date. More than 11,000 adults with ADHD and caregivers of children with the condition participated in the survey from July to December 2023.

“We hesitated for a long time and tried diet changes first in an attempt to avoid medication,” said one respondent. “Although diet is very important, medication has given our child the opportunity to enjoy life by having more emotional control, better friendships, and the ability to complete work and think things through. Greater self-confidence flows from all of this.”

Most Popular ADHD Medications

To be clear, ADHD medication is not a quick fix. On average, children try 2.75 different medications and adults try 2.56 prescriptions before finding one that works for them. Survey respondents also said that 17% of children and 14% of adults cease treatment with medication for one reason or another — cessation rates lower than reported in other studies.1

Biggest Impediments to ADHD Treatment

Access to treatment professionals with experience in ADHD is the biggest impediment to effective treatment, according to both caregivers and adults. Other barriers include side effects, long wait times, poor access to diagnosing clinicians, and comorbid conditions that complicate evaluation and treatment (82% of children and 92% of adults with ADHD report comorbid diagnoses).

ADHD’s Most Common Comorbid Conditions

The average age of ADHD diagnosis in children is 8 for boys and 9 for girls, according to survey respondents. On average, adults not diagnosed as children learn of their ADHD around age 39. Most of these late diagnoses are among women, who report years of struggle preceding their diagnosis.

“I wish I had been diagnosed and treated sooner,” wrote one survey respondent. “The struggle is so profound and deep. And the longer you go through it without help or knowing what you’re really struggling with, the harder it feels to get others to hear and see you. You feel alone.”

Persistence, flexibility, and self-advocacy are vitally important when working to find the right medication. Though the trial-and-error phase was described as frustrating by most survey respondents, research tells us the benefits of ADHD medication use — reduced risks of automobile accidents, substance abuse, unwanted pregnancy, sexually transmitted diseases, and self harm in teens — are worthwhile and meaningful.2

“I wish I had known that ADHD medication helps prevent addictions to dangerous substances,” wrote one survey respondent, “and car accidents for people with ADHD.”

ADHD Medication Formulation, Duration & Satisfaction

Barely half of patients taking a long-acting medication are satisfied with its duration of coverage, which is 9.5 hours for children and 10 hours for adults, on average. This is a flunking grade, but it’s far superior to the satisfaction ratings for short-acting formulations. So why do up to 23 percent of children and 30 percent of adults take short-acting stimulants? Perhaps because clinicians are more likely to prescribe them, and some adults like the medications’ relative flexibility.

“Sometimes, in a social setting, I quite like taking only 5 mg of short-release (rather than my prescribed 10 mg),” wrote one survey respondent. “Other times, when working on something that I find really dull, I often take 15 mg (3 x 5 mg tablets).”

In the end, adults are more likely than children to take short-acting formulations, to be dissatisfied with their medications, and to be considering a switch, according to the survey data.

ADHD Medication Side Effects

Caregivers are likely to try fish oil, eliminate food dyes, and sign up for karate before considering a prescription for their child. Once they decide to try medication, caregivers prioritize finding the one with the fewest side effects.

At the same time, 53% of children who end up taking medication try methylphenidate, 36% take amphetamine, and just 11% take a non-stimulant. So given its popularity, methylphenidate must deliver the fewest side effects, right?

No. According to caregiver reports, slightly more children reported side effects from methylphenidate than amphetamine, and those side effects were nearly identical, with appetite suppression being the most common by far; it impacted 61% of children taking any stimulant.

Adults use amphetamine for what they cite as their top priority in choosing a medication: symptom control. Yet they gave it an efficacy rating that was only slightly better than methylphenidate, which is associated with fewer side effects.

So should more adults consider trying Concerta, Ritalin, or a newcomer like Azstarys? One-quarter to one-third of adults said they are now considering some kind of medication switch.

ADHD Treatments Scorecard

Most Highly Recommended ADHD Treatment Approaches

ADHD Treatment Approaches with Highest Efficacy Ratings

Rated According to Effectiveness on ADHD Symptoms, Specifically

What Readers Say vs. What They Do

The most highly recommended approach to managing ADHD symptoms (exercise) has been used by less than half of ADDitude survey respondents. The second most recommended approach among adults (ADHD coaching) has been adopted by only 17 percent of people. And the vitamins, minerals, and supplements used by 49 percent of people surveyed don’t even earn a passing grade. All of this hints at problems with availability, cost, and medical advice in the world of ADHD treatment.

Diet and Nutrition Approaches for ADHD

What dietary changes move the needle?

At least half of caregivers and adults reported that the following dietary changes have a positive impact on ADHD symptoms:

  • Decreasing or eliminating artificial colors/preservatives/sweeteners3
  • Decreasing or eliminating sugar4
  • Increasing protein

Research generally supports these observations and reader efficacy ratings are high. So why are fewer than 30% of caregivers and adults making dietary changes to address ADHD? For one, 61% of children using stimulant medication to treat their ADHD experience appetite suppression as a side effect, according to their caregivers. Dietitians generally advise that children should focus on eating first and eating heathy second.

“We struggle to get enough calories into our child due to decreased appetite,” wrote one parent. “We are happy to have her eat, regardless of what or when, to keep energy levels up.”

Psychotherapy More Prevalent Than ADHD Coaching

Though the recommendation rates are nearly identical, far more people engage in psychotherapy than work with an ADHD coach. Therapy generally helps clients work through comorbid conditions like anxiety and depression, and negative beliefs or self-defeating behaviors. Coaching helps to strengthen skills to mitigate ADHD deficits and reach goals, but its benefits are short-lived, readers say.

“ADHD coaching helped me to narrow down my biggest challenges and work on practical solutions for the day-to-day things I struggle with,” said one survey respondent.

Parent Training or Behavioral Therapy for ADHD

This first-line treatment is used by less than 6 out of 10 study participants.

The American Academy of Pediatrics recommends parent training in behavior management as a first-line ADHD treatment for children diagnosed before age 7, and a complementary treatment approach thereafter. Despite this recommendation, and a high rate of reported satisfaction, just more than half of parents say they’ve ever used it. Possible reasons for this: Clinicians aren’t recommending parent training nearly enough; behavioral therapists versed in ADHD are difficult to find; and/or therapy is expensive and time-consuming. Likely, all of these reasons are true.

“Changing the way we parented was a game changer,” wrote one survey respondent. “It brought the stress in the house down significantly and meant we could focus on the lagging skills and promoting the behaviors we wanted to see versus punishing behaviors we didn’t want to see.”

Exercise Is Invaluable and Infrequent

Does exercise eradicate ADHD symptoms? Hardly. Readers rated its efficacy on ADHD just 2.4 out of 5, but they also called it invaluable — especially vigorous cardiovascular morning exercise. It aids sleep, mood, and hyperactivity, our readers say. So why isn’t exercise a universal component of treatment plans? As we know, the ADHD brain is easily bored and resists routine.

“When I get into a good stride with routine exercise, it almost always goes hand-in-hand with better eating habits, better focus, energy levels, mental clarity, and stronger relationships and productivity,” said one adult with ADHD. “Exercise is undoubtedly a crucial piece of the (treatment) puzzle.”

Most Impairing Symptoms of ADHD

ADHD Treatment Options: Next Steps

Sources

1 Brikell I, Yao H, Li L, Astrup A, Gao L, Gillies MB, Xie T, Zhang-James Y, Dalsgaard S, Engeland A, Faraone SV, Haavik J, Hartman C, Ip P, Jakobsdóttir Smári U, Larsson H, Man KK, de Oliveira Costa J, Pearson SA, Hostrup Nielsen NP, Snieder H, Wimberley T, Wong IC, Zhang L, Zoega H, Klungsøyr K, Chang Z. ADHD medication discontinuation and persistence across the lifespan: a retrospective observational study using population-based databases. Lancet Psychiatry. 2024 Jan;11(1):16-26. doi: 10.1016/S2215-0366(23)00332-2. Epub 2023 Nov 27. PMID: 38035876.

2 Chang Z, Ghirardi L, Quinn PD, Asherson P, D’Onofrio BM, Larsson H. Risks and Benefits of Attention-Deficit/Hyperactivity Disorder Medication on Behavioral and Neuropsychiatric Outcomes: A Qualitative Review of Pharmacoepidemiology Studies Using Linked Prescription Databases. Biol Psychiatry. 2019 Sep 1;86(5):335-343. doi: 10.1016/j.biopsych.2019.04.009. Epub 2019 Apr 17. PMID: 31155139; PMCID: PMC6697582.

3 Rambler RM, Rinehart E, Boehmler W, Gait P, Moore J, Schlenker M, Kashyap R. A Review of the Association of Blue Food Coloring With Attention Deficit Hyperactivity Disorder Symptoms in Children. Cureus. 2022 Sep 16;14(9):e29241. doi: 10.7759/cureus.29241. PMID: 36262950; PMCID: PMC9573786.

4 Johnson RJ, Wilson WL, Bland ST, Lanaspa MA. Fructose and uric acid as drivers of a hyperactive foraging response: A clue to behavioral disorders associated with impulsivity or mania? Evol Hum Behav. 2021;42(3):194-203. doi:10.1016/j.evolhumbehav.2020.09.006

]]>
https://www.additudemag.com/adhd-treatments-scorecard-medication-therapy-supplements-exercise/feed/ 1 347307
2024 Scorecard of ADHD Treatments https://www.additudemag.com/download/adhd-treatments-scorecard-medication-supplements-therapy/ https://www.additudemag.com/download/adhd-treatments-scorecard-medication-supplements-therapy/?noamp=mobile#respond Wed, 10 Jan 2024 21:00:11 +0000 https://www.additudemag.com/?post_type=download&p=345890

ADDitude Reader Survey Reveals ADHD Treatment Trends & Barriers to Care

In mid-2023, the ADDitude editorial team designed an 85-question ADHD treatment survey and invited responses from 978,871 opt-in newsletter subscribers, 11,013 of whom answered the survey. Data were collected between July 30 and December 4, 2023, and analyzed by ADDitude editors.

Top 10 Research Insights

1. The greatest impediment to effective ADHD healthcare is access to treatment professionals with training and experience in ADHD.

2. At least 80% of children and 70% of adults taking stimulant medication experience persistent side effects, which are partly to blame for medication cessation.

3. Only 42% of parents opt to medicate their children within 6 months of diagnosis; however, waiting too long to medicate was the Number One regret expressed by caregivers.

4. 85% of people with ADHD end up taking medication and they rate its efficacy higher than any other treatment included in the survey.

5. Medication trial and error is seen as necessary but frustrating. On average, children try 2.75 different medications and adults try 2.56 prescriptions.

6. The first-line ADHD treatment recommended by the APA, parent training, is only reaching 57% of children. It is recommended by 93% of those who use it.

7. Complex ADHD is the norm, with 92% of adults and 82% of children reporting at least one additional diagnosis.

8. The top concern when choosing a medication is side effects for caregivers and symptom control for adults. On these measures, the differences between methylphenidate and amphetamine are miniscule.

9. Women diagnosed later in life cite years of misdiagnosis, frustrating medical interactions, and ineffective treatment.

10. Patients are not learning of the executive dysfunctions inherent in ADHD or the risks associated with NOT taking ADHD medication.

]]>
https://www.additudemag.com/download/adhd-treatments-scorecard-medication-supplements-therapy/feed/ 0 345890
Remembering Behavioral Therapy Advocate William E. Pelham, Jr., Ph.D. https://www.additudemag.com/william-pelham-behavioral-therapy-adhd-advocate/ https://www.additudemag.com/william-pelham-behavioral-therapy-adhd-advocate/?noamp=mobile#respond Wed, 15 Nov 2023 06:31:39 +0000 https://www.additudemag.com/?p=343326 November 15, 2023

William E. Pelham, Jr., Ph.D., a child psychologist, ADDitude contributor, and proponent of behavioral therapy for children with ADHD, died on October 21, 2023. He was 75.

Founding director of the Center for Children and Families at Florida International University (FIU) and distinguished professor of psychology, Pelham advocated that children with ADHD begin treatment with behavioral therapy and parental intervention techniques, adding low doses of stimulant medication if necessary.

“Bill is credited with decelerating the role of medication-first treatment regimens in favor of more evidence-based treatment programs…. [he] transformed the lives of countless children, adolescents, and their families all across the world, including thousands in South Florida,” wrote Elizabeth Bèjar, FIU Provost, Executive Vice President, and COO in an email to the university.

Pelham began his nearly 50-year career as a professor at Washington State University, training hundreds of scientists and clinicians working with children with ADHD. He also taught at Florida State University, the University of Pittsburgh, and the State University of New York at Buffalo.

“Dr. Pelham was one of the original giants in the field of ADHD research,” said James J. McGough, M.D., professor of psychiatry at the University of California, Los Angeles, in The New York Times.

In 1980, Pelham developed and directed a summer treatment program for children ages 6 to 12 with ADHD and related behavioral, emotional, and learning challenges. His camp was recognized as a model program for ADHD treatment in children and adolescents by the Society of Clinical Child and Adolescent Psychology (SCCAP), the American Psychological Association (APA), Children with Attention Deficit Disorder (CHADD), and the Substance Abuse and Mental Health Services Administration (SAMHSA).

He authored or co-authored more than 400 professional publications on dosing and sequencing in behavioral, pharmacological, and combined interventions for ADHD treatment. He was a fellow of the APA and the American Psychological Society and past president of the SCCAP and the International Society for Research in Child and Adolescent Psychopathology (ISRCAP). He also received countless awards, including the CHADD Hall of Fame Award (2002), the SCCAP Career Achievement Award (2009), and the 2012 Lifetime Achievement Award from the Society for the Science of Clinical Psychology.

Pelham is survived by his wife, Maureen, and his two children, William and Caroline.

]]>
https://www.additudemag.com/william-pelham-behavioral-therapy-adhd-advocate/feed/ 0 343326
The Future of ADHD Research Looks Like This https://www.additudemag.com/epigenetics-neuroimaging-brain-training-adhd-research/ https://www.additudemag.com/epigenetics-neuroimaging-brain-training-adhd-research/?noamp=mobile#respond Sun, 24 Sep 2023 09:41:22 +0000 https://www.additudemag.com/?p=339852 A substantial body of research over the years has found that ADHD is characterized by high heritability and involves many different genes, has replicable findings in neuroimaging studies, has effective treatments (both non-pharmacologic and pharmacologic), and is associated with adverse long-term outcomes. Yet many questions remain unanswered.

While no one can predict the scientific discoveries that lie ahead, three research areas are especially promising for improving our understanding of ADHD: neuroimaging, genetic research, and non-pharmacologic interventions, like transcranial magnetic stimulation and attention training.

3 Key ADHD Research Areas

  1. Neuroimaging

    Advances in brain-imaging techniques may lead to a better understanding of the neural mechanisms underlying ADHD. There are caveats, however. It appears that single neuroimaging receptor or cellular studies have provided clues about differences in brain structure and functioning in individuals with ADHD, but the brain comprises billions of interacting cells, circuits, and networks that do or do not work together during specific tasks.

[Free Download: Learn the Facts About Neurofeedback]

These complex networks and connections vary by individual and by the specific tasks that are part of many neuroimaging studies. Researchers are asking:

  • How do different individuals recruit different brain networks and connections to perform a specific task?
  • How are additional connections used if the specific tasks are (or are not) related to emotional regulation, excitement, familiarity, fear, or task difficulty?

Slowly, the field is moving away from static representations of cellular or receptor activities in specific brain regions and looking instead at how the whole brain (rather than the simple sum of its single parts) functions. Neuroimaging tools (i.e., Brain SPECT, PET and CAT scans, and fMRI) cannot yet make an accurate diagnosis of ADHD, but we’ll look for important breakthroughs in this area.

  1. Epigenetic Research

    Further exploration of genetic factors could shed light on the heritability of ADHD and pave the way for targeted therapies based on an individual’s genetic profile. While the study of genetic factors has provided important clues, we now know that there is no single gene or small set of genes that reliably predict whether someone will have ADHD. Moreover, the specific genes that put one individual at risk for ADHD may differ from those found in another person with ADHD.

This is where epigenetic research comes into play. Researchers are asking:

  • Which genes might predispose a child to develop ADHD due to exposure to prenatal and perinatal tobacco smoke or a stressful environment?
  • Are there ways to offset these influences by changing an individual’s environment, and at what period during development?

[New Class! The Adult’s Guide to ADHD Diagnosis]

As we discover more specific gene and brain developmental pathways, we should expect to find that different and precise interventions work for different ADHD subtypes, depending on the individual’s particular gene-environment mix and how factors unfold over time.

  1. Non-pharmacologic Interventions

    Cognitive-behavioral therapies, neurofeedback, and computerized attention training programs have expanded our treatment options beyond medication.

Technologies using video game formats to provide specific brain exercises may lead to potential attentional benefits, presumably by strengthening specific brain circuits. Examples of brain training programs include EndeavorRX, Joon, Mightier, and Calmsie.

Neurostimulation devices offer new techniques for managing ADHD symptoms more effectively. Examples include the Monarch eTNS system, which uses an external wearable device that stimulates the Vagus nerve, as well as devices that deliver transcranial magnetic stimulation (TMS) to the brain through an externally applied device. While TMS has been approved for depression, anxiety, and obsessive-compulsive disorder, it has been studied but not yet approved for ADHD.

These new interventions are exciting; however, we do not have sufficient research data comparing the efficacy of any of these treatments with more established and efficacious pharmacologic interventions and cognitive behavior therapies.

ADHD Research Updates: Next Steps

Peter S. Jensen, M.D., is the founder of The REACH Institute, which trains clinicians to effectively diagnose and treat mental health conditions in children.


SUPPORT ADDITUDE
Thank you for reading ADDitude. To support our mission of providing ADHD education and support, please consider subscribing. Your readership and support help make our content and outreach possible. Thank you.

]]>
https://www.additudemag.com/epigenetics-neuroimaging-brain-training-adhd-research/feed/ 0 339852
“EMDR Therapy Helps People Heal From Experiences That Haunt Them” https://www.additudemag.com/emdr-therapy-eye-movement-desensitization-trauma-adhd/ https://www.additudemag.com/emdr-therapy-eye-movement-desensitization-trauma-adhd/?noamp=mobile#respond Fri, 21 Jul 2023 09:58:28 +0000 https://www.additudemag.com/?p=335275 The following is a personal essay, and not a medical recommendation endorsed by ADDitude. For more information about EMDR therapy, speak with your physician.

Just as overeating can overwhelm our digestive systems and cause us to develop symptoms of indigestion, traumatic experiences can get “stuck” in our nervous system, leading to ongoing distress and negative emotions and beliefs. Eye movement desensitization and reprocessing (EMDR) therapy helps individuals heal from the experiences that haunt them rather than simply learn to cope with them.

EMDR can be especially beneficial for adults with ADHD or comorbid conditions, such as anxiety, depression, or post-traumatic stress disorder (PTSD), because it targets underlying traumatic experiences (i.e., childhood abuse, shame, neglect, bullying, etc.) that may contribute to symptoms. The evidence-based therapy works by engaging several neurophysiological processes, which is a fancy way of saying that EMDR relies on the nervous system’s natural healing abilities to reprocess a distressing memory or experience, ultimately reducing or eliminating debilitating symptoms.1

The key component of EMDR is bilateral stimulation (BLS) — the therapy doesn’t work without it. BLS stimulates both sides of the brain through eye movements, tapping, or listening to alternating tones. It stimulates similar processes experienced during the rapid eye movement (REM) sleep phase, an essential part of memory consolidation. BLS “taxes” or “breaks” a targeted memory, making it hard for a client to focus on it causing the memory to lose its negative emotional charge. A client can still recall a negative memory just without the negative feelings.

How Does EMDR Work?

A misconception about EMDR is that it’s a magic bullet and will work seamlessly for everyone. That’s not true. The therapy takes time and preparation to work effectively. The client and therapist focus on building coping skills and a safe therapeutic relationship before identifying memories to target and treat using EMDR techniques.

In total, EMDR therapy consists of eight phases, including: 2,3

EMDR Phase 1: Client History

The therapist takes a detailed client history to identify their readiness and suitability for treatment.

EMDR Phase 2: Preparation

The therapist sets reasonable expectations and trains the client on various self-control techniques to maintain stability between and during the sessions.

[Get Our Free Guide to Natural Treatment Options]

EMDR Phase 3: Assessment

The client and therapist jointly identify the target memory on which they will work.

EMDR Phase 4: Desensitization

The client uses BLS to change the targeted memory’s trauma-related sensory experiences and associations.

EMDR Phase 5: Installation

The client identifies the new positive statements and associations they hold about the experience, now that it’s resolved.

EMDR Phase 6: Body Scan

The client scans their body for any somatic response related to the targeted memory. If present, the therapist targets this body sensation for further processing.

EMDR Phase 7: Closure

The therapist explains what to expect between sessions and asks the client to record any disturbances experienced between sessions. The therapist also takes time to help relieve any distress from the session so the client feels regulated upon leaving the session.

EMDR Phase 8: Reassessment

The therapist evaluates the EMDR treatment’s effectiveness.

A typical EMDR session lasts one hour; however, some therapists offer intensive sessions for 90 minutes or several hours. It may take several sessions to process a targeted memory. Clients who have experienced complex trauma may need several months of EMDR therapy; clients who already have coping skills and aren’t afraid to feel emotions and body sensations may rapidly move through EMDR treatment in a few weeks. It depends on the client’s goals, the strength of their nervous system, and how many memories need to be processed.

After a successful EMDR session, my clients typically experience reduced distress and vividness associated with the negative memory and report that a previously difficult experience “no longer bothers them.” They also report reduced symptoms associated with the memory and more peace and joy in their lives.

[Free Self-Test: General Anxiety Disorder in Adults]

EMDR for Children

EMDR therapy is not only appropriate for adults. It is a child-friendly and developmentally appropriate therapy for children and adolescents. Therapists can tailor EMDR treatment to meet the needs of each child by using fun and engaging techniques, such as storytelling, drawing, and play therapy, to help children feel safe and comfortable while processing their traumas.

More importantly, EMDR therapy can help children with ADHD and comorbid conditions develop coping skills and strategies to manage their symptoms more effectively. For example, it can teach them relaxation techniques to reduce anxiety, improve their ability to focus and complete tasks, and help them develop healthy communication and relationship skills.

It is important to note that EMDR can be an overwhelming and vulnerable therapy; treatment should only occur with a trained EMDR professional — and only after both the professional and client are ready for it.

By helping individuals process and release negative emotions associated with traumatic experiences, EMDR therapy can alleviate anxiety, depression, and PTSD symptoms and even reduce some symptoms associated with ADHD. While EMDR will not alleviate an ADHD diagnosis, it can help those who struggle with ADHD symptoms live a happier, more productive life. EMDR helps clients to develop a more positive self-image, self-confidence, and live a better quality of life.

To find a licensed EMDR professional, visit emdria.org.

EMDR Therapy: Next Steps

Rebecca Kase, MSW, LCSW, RYT, a member of emdria.org, and an emdria-approved trainer and consultant.

The opinions expressed in ADDitude Guest Blogs are solely those of the User, who may or may not have medical or scientific training. These opinions do not represent the opinions of ADDitude. Blogs are not reviewed by an ADDitude physician or any member of the ADDitude editorial staff for accuracy, balance, objectivity, or any other reason except for compliance with our Terms and Conditions. Some of these opinions may contain information about treatments or uses of drug products that have not been approved by the U.S. Food and Drug Administration. ADDitude does not endorse any specific product, service or treatment.

Do not consider ADDitude Blogs as medical advice. Never delay or disregard seeking professional medical advice from your doctor or other qualified healthcare provider because of something you have read on ADDitude. You should always speak with your doctor before you start, stop, or change any prescribed part of your care plan or treatment. ADDitude understands that reading individual, real-life experiences can be a helpful resource, but it is never a substitute for professional medical advice, diagnosis, or treatment from a qualified health care provider. If you think you may have a medical emergency, call your doctor or dial 911 immediately.


SUPPORT ADDITUDE
Thank you for reading ADDitude. To support our mission of providing ADHD education and support, please consider subscribing. Your readership and support help make our content and outreach possible. Thank you.

Sources

1Psychological and Physical Symptoms Stemming from Adverse Life Experiences. (2014). Perm J. https://doi.org/10.7812/tpp/13-098

2Shapiro F. EMDR Therapy Training Manual. Watsonville, CA: EMDR Institute; 2012.

3Menon, S.B., Jayan, C. (2010) Eye Movement Desensitization and Reprocessing: A Conceptual Framework. Indian J Psychol Med. https://doi.org/10.4103/0253-7176.7851

]]>
https://www.additudemag.com/emdr-therapy-eye-movement-desensitization-trauma-adhd/feed/ 0 335275
EndeavorRx https://www.additudemag.com/treatment/endeavorrx/ https://www.additudemag.com/treatment/endeavorrx/?noamp=mobile#respond Sun, 16 Jul 2023 20:09:36 +0000 https://www.additudemag.com/?post_type=treatment&p=335643 What Is EndeavorRx?

EndeavorRx is a digital therapeutic authorized by the Food and Drug Administration for the treatment of children ages 8 to 12 with primarily inattentive or combined-type ADHD. In the U.S., EndeavorRx is indicated to improve attention as measured by computer-based testing, and it is available by prescription from a licensed health care provider.

EndeavorRx is not intended to be used as a stand-alone therapeutic and is not a substitution for a child’s ADHD medication.

Developed by Akili Interactive, EndeavorRx is the first game-based digital therapeutic device to receive marketing and prescription authorization by the FDA for any type of condition. It has also received Conformité Européenne (CE) Mark certification in Europe.

How Does EndeavorRx Work?

Through its immersive video game experience, EndeavorRx presents specific sensory stimuli and simultaneous motor challenges designed to target neural systems in the brain related to attentional control. Children interact with EndeavorRx on mobile devices, and they typically play for 25 minutes per day, 5 days a week.

The EndeavorRx games, which challenge players to multitask and ignore distractions, are designed to target areas of the brain tied to attention control.

How Long Does EndeavorRx Take to Work?

A randomized, controlled clinical study conducted by parent company Akili Interactive showed improvement, as measured by the Test of Variable Attention (TOVA), on at least one measure of objective attention within four weeks of beginning treatment with EndeavorRx.1 Akili reports that a more recent trial demonstrated that 68% of parents reported improvements in ADHD-related impairments after two months of treatment.1

What are the Side Effects of EndeavorRx?

In EndeavorRx trials, fewer than 10% of participants experienced treatment-related adverse events including frustration, headaches, dizziness, emotional reactions, nausea, and aggression. All such events were transient and did not carry lasting effects.1

What Precautions are Associated with EndeavorRx?

EndeavorRx may not be appropriate for patients with photo-sensitive epilepsy, color blindness, or physical limitations that restrict use of a mobile device; parents should consult with their child’s healthcare provider.

Learn more about EndeavorRx at https://www.endeavorrx.com/

What is EndeavorOTC?

EndeavorOTC is a video game app clinically designed to treat symptoms of inattentive ADHD in adults. It was developed by Akili using the same proprietary technology behind EndeavorRx. According to Akili, adults who participated in a clinical trial studying the app showed improved focus and attention, and reported a better quality of life, including completing tasks on time, multitasking, and keeping track of personal items. EndeavorOTC is available without a prescription for adults 18 and older through the iOS Apple store and Google Play Store. Learn more about EndeavorOTC at https://www.endeavorotc.com/.

Sources

1 Kollins, S. H., DeLoss, D. J., Cañadas, E., Lutz, J., Findling, R. L., Keefe, R. S. E., Epstein, J. N., Cutler, A. J., & Faraone, S. V. (2020). A novel digital intervention for actively reducing severity of paediatric ADHD (STARS-ADHD): a randomised controlled trial. The Lancet. Digital health, 2(4), e168–e178. https://doi.org/10.1016/S2589-7500(20)30017-0

2 Kollins, S. H., Childress, A., Heusser, A. C., & Lutz, J. (2021). Effectiveness of a digital therapeutic as adjunct to treatment with medication in pediatric ADHD. NPJ digital medicine, 4(1), 58. https://doi.org/10.1038/s41746-021-00429-0

]]>
https://www.additudemag.com/treatment/endeavorrx/feed/ 0 335643
“Unlocking the Future of ADHD: Advances in Research, Diagnosis, & Treatment” [Video Replay & Podcast #468] https://www.additudemag.com/webinar/what-causes-adhd-advances-research-diagnosis-treatment/ https://www.additudemag.com/webinar/what-causes-adhd-advances-research-diagnosis-treatment/?noamp=mobile#respond Thu, 29 Jun 2023 15:12:42 +0000 https://www.additudemag.com/?post_type=webinar&p=334884 Episode Description

The exact causes of ADHD are not yet known. ADHD is believed to be highly heritable —researchers have made strides in recent years identifying genes involved in the disorder — but it is also understood that ADHD may be influenced by non-inherited risk factors, such as trauma and stress. With scientific advances in the next decade or more, and perhaps with the aid of AI, we could see the diagnosis of many more subtypes of ADHD and new kinds of treatments involving novel therapies.

In this webinar, you will learn:

  • About the current research involving genetic influences and environmental factors associated with ADHD
  • How scientific discoveries could lead to the recognition of more than a dozen subtypes, and the implication of such findings
  • How scientific advances may one day lead to the prevention of ADHD in utero or in the first two years of life
  • About the future of promising therapies to retrain the brain to compensate for executive function weaknesses stemming from ADHD

Watch the Video Replay

Enter your email address in the box above labeled “Video Replay + Slide Access” to watch the video replay (closed captions available) and download the slide presentation.

Download or Stream the Podcast Audio

Click the play button below to listen to this episode directly in your browser, click the symbol to download to listen later, or open in your podcasts app: Apple Podcasts; Google Podcasts; Audacy; Spotify; Amazon Music; iHeartRADIO.

More on ADHD Research, Diagnosis, and Treatment

Obtain a Certificate of Attendance

If you attended the live webinar on August 23, 2023, watched the video replay, or listened to the podcast, you may purchase a certificate of attendance option (cost: $10). Note: ADDitude does not offer CEU credits. Click here to purchase the certificate of attendance option »


Meet the Expert Speaker

Peter S. Jensen, M.D., founded the REACH Institute in 2006 to improve access to mental health care for children by training healthcare professionals in the diagnosis and treatment of common disorders. Previously, Dr. Jensen was an Associate Director of Child and Adolescent Research at the National Institute of Mental Health (NIMH). He left NIMH and served as the founding director of the Center for the Advancement of Children’s Mental Health at Columbia University. While there, he developed the core methods REACH uses today to close the gap between science and practice. The strategy was to bring together leading scientists, mental health experts and agencies, primary care providers, parents, and schools to identify the best scientific findings available to help children. Then Dr. Jensen led REACH to implement, disseminate, and evaluate these methods.

The result was The REACH Institute’s first and most popular course, Patient-Centered Mental Health in Pediatric Primary Care. This course has trained more than 6,000 primary care providers to help children and teens with mental health issues.


Listener Testimonials

“This webinar was high-level and yet understandable! Such great information!”

“Almost every piece of information provided today will improve my practice and allow me to explain information more completely to my patients. Dr. Jensen is a gifted teacher. Thank you so much for this webinar.”

“I’ve been craving this information for so long I forgot how much I wanted it! ADDitude strikes again! Thanks!”


Webinar Sponsor

The sponsor of this ADDitude webinar is…

 

 

Play Attention: Research conducted at Tufts University School of Medicine demonstrates that Play Attention improves attention, behavior, executive function, and overall school performance. Harnessing cutting-edge NASA-inspired technology, Play Attention offers a sophisticated platform for improving executive function and self-regulation. Through our digital trainer, you can control personalized cognitive exercises using just your mind! Additionally, your program comes complete with a dedicated Personal Executive Function Coach who will tailor your plan as you progress. Both home and professional programs are available. Contact us at 828-676-2240 or click here to schedule your Live Demo and witness Play Attention in action!

ADDitude thanks our sponsors for supporting our webinars. Sponsorship has no influence on speaker selection or webinar content.


Follow ADDitude’s full ADHD Experts Podcast in your podcasts app:
Apple Podcasts | Google Podcasts | Spotify | Google Play | Amazon Music | RadioPublic | Pocket Casts | iHeartRADIO | Audacy

]]>
https://www.additudemag.com/webinar/what-causes-adhd-advances-research-diagnosis-treatment/feed/ 0 334884